Metis TechBio Co (HKSE:07666) ROIC %: -219.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:07666 Metis TechBio Co Ltd HKSE:07666
6 GF Score
Price HK$12.24
! 1 Warning Sign
View Full Analysis

What is Metis TechBio Co ROIC %?

Metis TechBio Co HKSE:07666 +2.00% 6 ROIC % is -219.00% as of Dec. 2025. GuruFocus rates HKSE:07666 with a GF Score™ of 6/100. The stock has 1 warning sign investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Metis TechBio Co's annualized return on invested capital (ROIC %) for the quarter that ended in Dec. 2025 was -219.00%.

As of today (2026-08-11), Metis TechBio Co's WACC % is 10.63%. Metis TechBio Co's ROIC % is -51.64% (calculated using TTM income statement data). Metis TechBio Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Metis TechBio Co  (HKSE:07666) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Metis TechBio Co's WACC % is 10.63%. Metis TechBio Co's ROIC % is -51.64% (calculated using TTM income statement data). Metis TechBio Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Metis TechBio Co ROIC % Related Terms


Metis TechBio Co ROIC % Historical Data

* Premium members only.

The historical data trend for Metis TechBio Co's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metis TechBio Co ROIC % Chart

Metis TechBio Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROIC %
-48.05 -63.45 -99.25 -123.36

Metis TechBio Co Quarterly Data
Dec22 Dec23 Dec24 Sep25 Dec25
ROIC % 0.00 0.00 -100.12 0.00 -219.00

HKSE:07666 vs VRTX, REGN, RVMD: ROIC % Comparison

For the Biotechnology subindustry, Metis TechBio Co's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Metis TechBio Co ROIC % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Metis TechBio Co's ROIC % distribution charts can be found below:

* The bar in red indicates where Metis TechBio Co's ROIC % falls into.


HKSE:07666
6GF Score
Metis TechBio Co Ltd HKSE:07666
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metis TechBio Co ROIC % Calculation

Metis TechBio Co's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROIC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=-391.089 * ( 1 - 0% )/( (339.145 + 294.933)/ 2 )
=-391.089/317.039
=-123.36 %

where

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1119.492 - 22.267 - ( 841.522 - max(0, 116.831 - 874.911+841.522))
=339.145

Invested Capital(A: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1425.391 - 51.434 - ( 1243.373 - max(0, 190.243 - 1269.267+1243.373))
=294.933

Metis TechBio Co's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Dec. 2025 is calculated as:

ROIC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-628.952 * ( 1 - 0% )/( (279.45 + 294.933)/ 2 )
=-628.952/287.1915
=-219.00 %

where

Invested Capital(Q: Sep. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1475.906 - 46.383 - ( 1227.257 - max(0, 187.466 - 1337.539+1227.257))
=279.45

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1425.391 - 51.434 - ( 1243.373 - max(0, 190.243 - 1269.267+1243.373))
=294.933

Note: The Operating Income data used here is four times the quarterly (Dec. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of -219.00% mean?
Metis TechBio Co (HKSE:07666) has a ROIC % of -219.00% as of Dec. 2025. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Metis TechBio Co and its competitors.
Is Metis TechBio Co's ROIC % too high?
Metis TechBio Co's current ROIC % is -219.00%. Overall, Metis TechBio Co has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Metis TechBio Co's ROIC % compare to VRTX and REGN?
Metis TechBio Co's ROIC % of -219.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Biotechnology company?
A good ROIC % depends on the Biotechnology industry context. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Metis TechBio Co and its competitors. Metis TechBio Co's current ROIC % is -219.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metis TechBio Co stock overvalued right now?
Metis TechBio Co (HKSE:07666) has a current ROIC % of -219.00%. The current ROIC % is -219.00%. Metis TechBio Co's overall GF Score™ is 6/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For Metis TechBio Co (HKSE:07666), the current ROIC % is -219.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Metis TechBio Co Business Description

Other Exchanges RO9:Germany
Address No. 21 Tianhe West Road, Room 201, 2nd Floor, Building 13, Daxing Biomedical Industry Base, Zhongguancun Science Park, Daxing District, Beijing, CHN
Metis TechBio Co Ltd is an investment holding company. The company and its subsidiaries are principally engaged in AI-empowered nanomaterial innovation for the delivery and application of active agents across all carbon-based life forms. Its technology platform, NanoForge, comprises a set of integrated tools, including a lipid library, AI models, an AI agent (METiS), quantum chemistry and molecular dynamics simulations, and high-throughput screening platforms. The company has developed three solution platforms (AiTEM, AiLNP, and AiRNA) designed to simulate, predict, and interpret nanoscale interactions, enabling the rational design, optimization, and validation of nanomaterials and their associated payloads.
6GF Score

Get the complete analysis for HKSE:07666

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$12.24
Price